Korea Biotech Slightly Increases Stake in Harim Holdings to 18.71%… Acquires 63,892 Shares via Open Market Purchase
Korea Biotech purchased 63,892 common shares of Harim Holdings on May 28, 2026 at 11,969 won per share via open market purchase, increasing its stake from 18.65% to 18.71% (+0.06%p)
The acquisition size is negligible relative to total outstanding shares, not affecting control or stock price materially
This stake increase can be interpreted as a routine portfolio adjustment by a major shareholder (over 10%)
[AI Comprehensive Analysis]This disclosure reports a minor stake change from a small open market purchase, representing a neutral event with no significant impact on enterprise value or stock outlook.
KOSDAQ Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders